Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: A multicentre randomised double-blind study

David Chadwick, J. Baldy-Moulinier, E. Ben-Manachem, R. Beran, A. Bes, L. D. Biermann, J. M. Bird, L. Boon, E. Byrne, E. P. Calandre, E. V. de Seijas, J. A. Tejerina, R. Canger, A. Saltarelli, N. E F Cartlidge, R. N. Corston, V. Cosi, C. Dellaportas, J. Duncan, W. Van PaesschenM. Dam, G. Danta, H. Gadot, A. N. Gale, D. Gisselbrecht, M. Gross, W. M. Guldenpfennig, J. Haan, S. J L Howell, G. S. Venables, J. Jankovic, R. Kälviäinen, P. Riekkinen, K. Kennedy, G. Kramer, P. H. Kritzinger, J. Manelis, R. Michelucci, C. A. Tassinari, M. Neufeld, B. Pederson, F. Pisani, A. Reches, B. Ried, E. A C M Saunders, E. Somerville, L. Spechio, L. A. Neve, L. Tramacere, H. Stefan, A. Tartara, A. D. Van As, C. A. Van Donsellar, M. Weber, H. G. Wieser, G. Zaccara, G. T. Gomez

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: A multicentre randomised double-blind study'. Together they form a unique fingerprint.

Medicine & Life Sciences